Menopause Endocrine Cardiovascular Risks
The menopausal transition is not simply a local shutdown of reproductive function; it is a far-reaching neuroendocrine reconfiguration marked by declining levels and unpredictable oscillations of ovarian steroids. For the female brain, this shift functions like a metabolic “reset.”
Can Heart Disease Be Cured?
Clinical Paradigms of Disease Resolution: Biological Differentiation between the Cure of Pathological Processes and the Reversal of Structural Damage
The medical community has historically distinguished between the resolution of acute illness and the long-term management of chronic disease. As lifestyle medicine has matured into a formal clinical discipline, it has exposed a critical gap in medical taxonomy: the failure to clearly differentiate between the cure of an active pathological process and the reversal of structural damage produced by that process.
The Invisible Infarction: A Deep Research Verification of Mechanisms, Diagnosis, and Management in MINOCA
Executive Summary: The Paradigm Shift in Acute Coronary Syndromes
For much of modern cardiology, acute myocardial infarction (AMI) has been dominated by a “plumbing model”: atherosclerotic plaque accumulates over years, progressively narrows the coronary lumen, and ultimately ruptures, triggering thrombosis and an abrupt, flow-limiting occlusion.
Physiological Optimization and Lifespan Performance Modeling in Elite Masters Cycling
What Peter Megdal’s World Hour Record Reveals About Aging, Fitness, and Cardiovascular Recovery
For decades, human athletic performance was assumed to follow a largely linear decline beginning in early adulthood. Conventional physiological models predicted that the cardiovascular system, pulmonary capacity, and skeletal muscle function would steadily deteriorate as cellular senescence accumulated.
A New Way of Looking Inside Your Heart Without Surgery – The Best Way to Predict a Heart Attack
The Bergström Study and the Paradigm Shift in Primary Prevention
The publication of the Bergström et al. study in the Journal of the American Medical Association (JAMA) on November 9, 2025, represents a landmark moment in the transition from population-based risk estimation to individualized, disease-based risk assessment.¹ This observational cohort study, conducted as part of the Swedish Cardiopulmonary Bioimage Study (SCAPIS), analyzed 24,791 individuals aged 50 to 64 years without established cardiovascular disease.